Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 589
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02421536 | Vibrent Smartphone Mobile Application | ||
| NCT00278109 | Partial Breast Irradiation With Chemotherapy | ||
| NCT00681304 | Ultrasound Based Localization of Lumpectomy Bed in Anatomical Coordinate System | ||
| NCT02405221 | Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer | ||
| NCT02478125 | Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer | ||
| NCT00809341 | R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma | ||
| NCT00425477 | Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia | ||
| NCT00077558 | 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome | ||
| NCT01937052 | Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database | ||
| NCT02215876 | Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer | ||
| NCT06205836 | Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer | ||
| NCT00287872 | Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma | ||
| NCT07439172 | Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma. | ||
| NCT02120157 | Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies | ||
| NCT02389738 | Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration | ||
| NCT05995821 | Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies | ||
| NCT03542604 | Cancer, Obesity/Overweight and Insomnia Study | ||
| NCT00003616 | Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma | ||
| NCT03573648 | Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer | ||
| NCT00025675 | Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors | ||
| NCT00484601 | Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma | ||
| NCT03218163 | MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma | ||
| NCT00003340 | Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia | ||
| NCT01752023 | A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC. | ||
| NCT00003243 | Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer | ||
| NCT00072449 | Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma | ||
| NCT00245011 | Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma | ||
| NCT00258206 | Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma | ||
| NCT01784081 | Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer | ||
| NCT05013216 | Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer | ||
| NCT00788164 | Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia | ||
| NCT00471653 | Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy | ||
| NCT00003289 | UCN-01 in Treating Patients With Advanced Cancer | ||
| NCT02111174 | Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy | ||
| NCT00469820 | Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell Transplant | ||
| NCT02017704 | Chemoradiation or Brachytherapy for Rectal Cancer | ||
| NCT00867308 | Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia | ||
| NCT01858558 | Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma | ||
| NCT01966289 | SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) | ||
| NCT01836068 | Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals | ||
| NCT00999622 | Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma | ||
| NCT02575222 | Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma | ||
| NCT00010049 | Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma | ||
| NCT00095771 | Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas | ||
| NCT04019964 | Nivolumab in Biochemically Recurrent dMMR Prostate Cancer | ||
| NCT02188563 | A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers | ||
| NCT00681993 | Trial of Partial Breast Irradiation With Various Concurrent Chemotherapy Regimens | ||
| NCT02286921 | Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resistance | ||
| NCT03044613 | Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer | ||
| NCT00003960 | Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer |
